Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …

There is a mechanistic link between the gut-derived metabolite trimethylamine-N-oxide
(TMAO) and obesity-related diseases, suggesting that the TMAO pathway may also be …

Nonalcoholic liver disease (NAFLD) is a hot topic for gastroenterologists and hepatologists
and clinical practitioners must be kept abreast with the rapid progress of knowledge in this …

Importance Several oral antidiabetic drug (OAD) classes can potentially improve patient
outcomes in nonalcoholic fatty liver disease (NAFLD) to varying degrees, but clinical data on …

Abstract Background and Aim Little is known about the diagnostic value of hepatic steatosis
index (HSI) and fatty liver index (FLI), as well as their link to metabolic syndrome in type 1 …

Background Obesity, mainly visceral obesity, and metabolic syndrome (MetS) are major risk
factors for the development of type 2 diabetes, cardiovascular diseases, and cancer. Data …

Vitamin D deficiency and obesity are two public health problems extensively exacerbated
over the last years. Among the several mechanisms proposed to account for the complex …

The prevalence of non-alcoholic-fatty-liver-disease (NAFLD) is associated with obesity,
diabetes, and metabolic syndrome (MS). This study aimed to evaluate the influence of two …

Aim: The aim of this study was the evaluation of the prevalence of NAFLD in patients with
type 2 diabetes mellitus. Background: Non-alcoholic fatty liver disease (NAFLD) is an …

Background and aim Nonalcoholic fatty liver disease (NAFLD) is becoming the leading
cause of chronic liver disease in China. The early identification and management of patients …